Skip to main content
. 2010 Jan;18(1):18–24.

Table 1.

Baseline patient characteristics (n=30).

Male gender, n (%) 15 (50.0)
Age, years, mean ± SD 80.5±7.7
Hypertension, n (%) 17 (56.7)
Diabetes mellitus, n (%) 11 (36.7)
Chronic renal insufficiency,a n (%) 10 (33.3)
Peripheral vascular disease,b n (%) 5 (16.7)
Coronary artery disease, n (%) 13 (43.3)
Congestive heart failure, n (%) 10 (33.3)
Prior myocardial infarction, n (%) 2 (6.7)
Prior stroke, n (%) 2 (6.7)
Prior bypass graft surgery, n (%) 3 (10.0)
Prior percutaneous coronary intervention, n (%) 7 (23.3)
Chronic atrial fibrillation, n (%) 12 (40.0)
Chronic pulmonary disease,c n (%) 6 (20.0)
Pulmonary hypertension,d n (%) 23 (76.7)
Permanent pacemaker, n (%) 2 (6.7)
NYHA class, n (%)
- I 0 (0.0)
- II 7 (23.3)
- III 13 (43.3)
- IV 10 (33.3)
Left ventricular function, n (%)
- Poor 2 (6.7)
- Moderate 5 (16.7)
- Good 23 (76.7)
Logistic EuroSCORE, mean ± SD 15±10
STS Risk score, mean ± SD 5.2±2.9
Peak pressure gradient, mm Hg, mean ± SD 79±25
Mean pressure gradient, mm Hg, mean ± SD 52±20
Aortic valve area, cm2, mean ± SD 0.71±0.19

a Renal insufficiency=estimated glomerular filtration rate <60 using the four-variable modified diet in renal disease (MDRD) equation : eGFR (ml/min/1.73 m2) = 32788 × serum creatinine −1.154 × age −0.203 × 0.742 [if the patient is female] × 1.210 [if the patient is black]. Where serum creatinine is in μ;g/dl, and age is in years. b Peripheral vascular disease is defined by a history of symptomatic claudication, previous or planned intervention on abdominal aorta or limb arteries and/or evident peripheral arterial disease on angiogram. c Chronic pulmonary disease=a history of respiratory problems associated with maintenance inhaled bronchodilator therapy. d Pulmonary hypertension=pulmonary artery systolic pressure >30 mmHg.